ghmpns | 20759

MPN sequential testing (blood)

Keywords

CALR Exon 9 Mutation, JAK2 Mutation Exon 12, JAK2 Mutation p.V617F, MPL p.W515 Mutation, Myeloproliferation, Myleoproliferative Neoplasm

Material

Blood EDTA
EDTA tube, purple (6)

Note

JAK2 p.V617F Mutation > JAK2 Exon 12 Mutations > CALR Exon 9 Mutations > MPL p.W515 Mutation | To be determined within 24h from sampling. | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent).

Min. quantity

4 mL

Stability

1 day / 18-25°C; 4 days / 2-8°C

Duration

5 days

Frequency

2 x per week

Method

Next Generation Sequencing

Price

CHF 954.90

Tariff

954.90 TP

Single analyses

MPL p.W515 Mutationen ghmpl Blut EDTA	ghmpl	Blut EDTA
CALR Exon 9 Mutationen Diagnose ghcal Blut EDTA	ghcal	Blut EDTA
JAK2 Exon 12 Mutationen jak2e Blut EDTA	jak2e	Blut EDTA
JAK2 p.V617F Mutation Diagnose jak2 Blut EDTA	jak2	Blut EDTA

Team of consultants

MD FMH hematology, FAMH Specialist in laboratory medicine Maurice Redondo Head of Routine laboratories	Head of Routine laboratories	T +41 61 486 11 11
PhD Christian Kalberer FAMH Specialist in laboratory medicine, main field hematology	FAMH Specialist in laboratory medicine, main field hematology	T +41 61 486 15 14
MD Boris E. Schleiffenbaum FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology	FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology	T +41 76 422 83 00